Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
COAG compared with GHRS: revenue, margins and what each company keeps, and the suppliers and customers both name
COAG
Hemab Therapeutics Holdings, Inc.
Change
Mkt cap
Revenue
Revenue
GHRS
GH Research PLC
Change
Mkt cap
Revenue
Revenue
vs
Compare
COAG
Hemab Therapeutics Holdings, Inc.
vs
GHRS
GH Research PLC
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
COAG
1 of 4 reports
Report
implied
realized
× implied
Q2 FY26
—
▲
+3.75%
—
GHRS
No earnings history for GHRS.
= implied
COAG realized, solid
GHRS realized, hatched
One scale, both sides: full bar = 4%
× = |realized| ÷ implied
Source: market data
COAG
Hemab Therapeutics Holdings, Inc.
Change
48.95
▲
+7.41%
· post 48.60
Mkt cap
$1.5B
GHRS
GH Research PLC
Change
18.56
▲
+0.65%
· post 18.56
Closed
Nov 6 '26
Mkt cap
$1.2B
vs
Compare
Closed
Nov 6 '26
COAG
Hemab Therapeutics Holdings, Inc.
vs
GHRS
GH Research PLC
48.95
▲
+7.41%
post 48.60
Price
18.56
▲
+0.65%
post 18.56
$1.5B
Mkt cap
$1.2B
Change
Change
COAG
48.95
▲
+7.41%
vs
GHRS
18.56
▲
+0.65%
Closed
Nov 6 '26